RIO DE JANEIRO, BRAZIL - "AstraZeneca's vaccine against Covid-19 is currently recommended for people aged between 18 and 64, based on the available data."
This is the conclusion of the report by the Robert Koch Institute (RKI), a recognized entity in Germany for infectious diseases, on the Oxford University and AstraZeneca pharmaceutical company's immunizer, which should be approved on Friday by the European Medicines Agency (EMA) to be used in all European Union member states. It is also the Brazilian government's choice, along with Coronavac, produced by the Butantan in partnership with the Chinese Sinovac laboratory.
The . . .